MCKESSON CORP MCK
NYSE · XNYS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Chart by TradingView
6/9
Piotroski F — financial health
0.59
Altman Z″ — distress risk · distress
8.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $403.4B | $4.8B | $14.6B | $5.7B | -$1.8B |
| 2025 | $359.1B | $3.3B | $13.3B | $5.5B | -$2.1B |
| 2024 | $309.0B | $3.0B | $12.8B | $3.9B | -$1.6B |
| 2023 | $276.7B | $3.6B | $12.4B | $4.8B | -$1.5B |
| 2022 | $264.0B | $1.1B | $13.1B | $4.0B | -$1.8B |
| 2021 | $238.2B | -$4.5B | $12.1B | $4.1B | $175.0M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.59 (distress)
- Working capital / assets -0.119
- Retained earnings / assets 0.271
- EBIT / assets 0.075
- Equity / liabilities -0.021
Source: SEC EDGAR filings · CIK 0000927653 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.